Sunesis Pharmaceuticals
| Region | Nordamerika |
| ISIN | US8673288747 |
| Sektor | Biotechnologie |
| Website | https://www.sunesis.com/ |
Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics. With a passion to advance novel drugs, we are inspired to make a difference in cancer patients' lives.
| Titel | Autor | Datum |
|---|---|---|
|
Risikoarmes "Peak Play" mit Multibagger-Potenzial
|
sharedeals | translation missing: de.datetime.time_ago_in_words.almost_x_years |
| Titel | Datum |
|---|---|
| MISC Group Q2 2025 profit falls to USD 97.5 mln | vor ungefähr 2 Monaten |
| MISC's 2Q25 Net Profit Slips 14% To RM464.4 Million On Weaker Engineering And Gas Segments | vor ungefähr 2 Monaten |
| MISC's Net Profit Down 7.1% To RM1.2 Billion On Lower Revenue | vor ungefähr 2 Monaten |
| MISC's 2Q profit down 14% on weaker gas and marine ops, declares eight sen dividend | vor ungefähr 2 Monaten |
| Bumi Armada-MISC merger falls through | vor ungefähr 2 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Suedzucker (1 Artikel) | |
| Stockholm IT Ventures AB (1 Artikel) | |
| Tahoe Resources (1 Artikel) | |
| Telit Communications (3 Artikel) | |
| Alle anzeigen | |